Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients

Fig. 3

Immunohistochemical staining for CD47 and CD68 in breast cancer with different molecular subtypes. A and B, The expression of CD47 (a) and CD68 (b) in TNBC. c, d The expression of CD47 (c) and CD68 (d) in HER2 overexpression breast cancer. e, f The expression of CD47 (e) and CD68 (f) in luminal-type breast cancer. 3,3′‑Diaminobenzidine staining (brown), nuclear counterstaining (haematoxylin)

Back to article page